AVITA Medical, Inc. (ASX:AVH) Insider Robert McNamara Purchases 10,000 Shares

AVITA Medical, Inc. (ASX:AVH) insider Robert McNamara purchased 10,000 shares of the business’s stock in a transaction dated Friday, February 21st. The shares were purchased at an average cost of A$10.09 ($6.31) per share, with a total value of A$100,900.00 ($63,062.50).

AVITA Medical Price Performance

The company has a debt-to-equity ratio of 0.36, a quick ratio of 9.32 and a current ratio of 8.18. The company has a market cap of $226.55 million, a price-to-earnings ratio of -5.55 and a beta of 1.54.

AVITA Medical Company Profile

AVITA Medical, Inc, together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions.